Valuation : ArcticZymes Technologies ASA

Market Cap 1.09B 117M 101M 94.71M 86.52M 162M 11.05B 162M 1.12B 434M 5.67B 439M 430M 18.26B P/E 2026 *
69.5x
P/E 2027 * 39.9x
Enterprise Value 809M 87.03M 74.89M 70.46M 64.37M 120M 8.22B 121M 833M 323M 4.22B 327M 320M 13.58B EV / Sales 2026 *
5.78x
EV / Sales 2027 * 4.88x
Free-Float
82.59%
Yield 2026 *
-
Yield 2027 * -
1 day-1.41%
1 week+2.44%
Current month+0.48%
1 month+6.87%
3 months+1.94%
6 months-10.64%
Current year+1.94%
1 week 20.5
Extreme 20.5
21.7
1 month 18.7
Extreme 18.7
22
Current year 18.3
Extreme 18.3
26.6
1 year 18.3
Extreme 18.3
31.4
3 years 12.34
Extreme 12.34
43.2
5 years 12.34
Extreme 12.34
100
10 years 3.5
Extreme 3.5
114.4
Manager TitleAgeSince
Chief Executive Officer - 18/09/2023
Director of Finance/CFO 51 01/10/2014
Chief Tech/Sci/R&D Officer 43 -
Director TitleAgeSince
Chairman 64 26/06/2024
Director/Board Member 62 26/06/2024
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
14/08/25 Buy

Director

2,852 0.0056%
04/06/25 Buy

Chief Operating Officer

3,400 0.0067%
14/05/25 Exercice

Chief Operating Officer

15,000 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%+2.44%-22.79%-32.80% 117M
-1.58%-2.59%+54.01%+104.98% 1,034B
-1.02%+2.92%+54.32%+71.68% 671B
-1.56%+0.27%+20.27%+75.34% 460B
+0.14%-0.47%+29.49%+38.56% 353B
-1.33%+4.72%+24.69%+45.55% 309B
-1.15%+0.30%-1.49%+12.31% 255B
-1.56%+1.11%+56.01%+72.03% 240B
-0.88%+1.15%-17.09%-54.39% 207B
-0.40%+3.48%+33.68%+100.57% 188B
Average -1.02%+1.38%+23.11%+43.38% 371.69B
Weighted average by Cap. -1.09%+1.04%+36.45%+66.44%

Financials

2026 *2027 *
Net sales 140M 15.06M 12.96M 12.19M 11.14M 20.83M 1.42B 20.89M 144M 55.9M 729M 56.54M 55.31M 2.35B 160M 17.23M 14.82M 13.95M 12.74M 23.83M 1.63B 23.9M 165M 63.95M 834M 64.68M 63.27M 2.69B
Net income 15.66M 1.68M 1.45M 1.36M 1.25M 2.33M 159M 2.34M 16.11M 6.25M 81.58M 6.32M 6.19M 263M 27.28M 2.93M 2.52M 2.38M 2.17M 4.06M 277M 4.07M 28.07M 10.89M 142M 11.02M 10.78M 458M
Net Debt -279M -29.95M -25.78M -24.25M -22.15M -41.44M -2.83B -41.56M -287M -111M -1.45B -112M -110M -4.67B -306M -32.94M -28.35M -26.67M -24.36M -45.58M -3.11B -45.7M -315M -122M -1.6B -124M -121M -5.14B
Logo ArcticZymes Technologies ASA
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Employees
51
Date Price Change Volume
04/09/26 NOK 21.00 -1.41% 12,735
03/09/26 NOK 21.30 +1.43% 38,669
02/09/26 NOK 21.00 +1.45% 17,620
01/09/26 NOK 20.70 -0.96% 9,097
31/08/26 NOK 20.90 +1.95% 56,868
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
21.30NOK
Average target price
28.00NOK
Spread / Average Target
+31.46%

Quarterly revenue - Rate of surprise